A5101582317- Helicobacter pylori-related gastroenterology studies
- Microscopic Colitis
- Inflammatory Bowel Disease
- Gastric Cancer Management and Outcomes
- Eosinophilic Esophagitis
- Gastroesophageal reflux and treatments
- Gut microbiota and health
- Nosocomial Infections in ICU
- Veterinary medicine and infectious diseases
- Pregnancy and Medication Impact
- Immune Response and Inflammation
- Liver Disease Diagnosis and Treatment
- Antibiotic Use and Resistance
- Pneumonia and Respiratory Infections
- Diet and metabolism studies
- Clinical Nutrition and Gastroenterology
Universidad Autónoma de Madrid
2021-2023
Hospital Universitario de La Princesa
2021-2023
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2021-2023
Effectiveness of vedolizumab in real world clinical practice is unknown.To evaluate the short and long-term effectiveness patients with inflammatory bowel disease (IBD).Patients who received at least 1 induction dose were included. was defined based on Harvey-Bradshaw index (HBI) Crohn's (CD) Partial Mayo Score (PMS) ulcerative colitis (UC). Short-term response assessed week 14. Variables associated short-term remission identified by logistic regression analysis. The Kaplan-Meier method used...
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe main epidemiological and clinical characteristics at diagnosis evolution disease, explore use drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 Spain were included followed-up for 1 year. (3) Results: We identified 3611 incident cases during 108 hospitals...
Abstract Background and Aims Inflammatory bowel disease (IBD) is a prevalent chronic noncurable associated with profound metabolic changes. The discovery of novel molecular indicators for unraveling IBD etiopathogenesis the diagnosis prognosis therefore pivotal. We sought to determine distinctive signatures from different subgroups before treatment initiation. Methods Serum urine samples newly diagnosed treatment-naïve patients age sex-matched healthy control (HC) individuals were...
Several methods are available to diagnose Helicobacter pylori infection. Our objective was evaluate the tests used for both initial diagnosis and confirmation of eradication after treatment in Europe.The European Registry on management infection is an international, multicentre, prospective, non-interventional registry aiming pylori-infected patients Europe. Countries with at least 100 cases registered from June 2013 April 2021, a validated diagnostic method were analysed. Data quality...
The recommended schedule for single capsule bismuth quadruple therapy (scBQT, Pylera) includes a proton pump inhibitor (PPI) two times day and three scBQT capsules four day. Four treatments are inconvenient reduce adherence. In contrast, adherence improves with schedules. clinical practice, many gastroenterologists use However, the effectiveness safety of this latter approach remain uncertain.To assess administered in patients included European Registry on Helicobacter pylori Management...